Loading...
360 High-Risk Vulnerability Immunization Tool V2.0 is a commercial vulnerability assessment tool by 360 Security Group (Qihoo 360). Sec1 Threat Vision is a commercial vulnerability assessment tool by Sec1. Compare features, ratings, integrations, and community reviews side by side to find the best vulnerability assessment fit for your security stack.
Based on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.
Mid-market and enterprise security teams managing dependencies across Java, Node.js, and Python ecosystems should use Sec1 Threat Vision for its 90-day vulnerability forecasting, which lets you patch before exploit code lands rather than chase CVEs after public disclosure. The AI-driven risk scoring operates on historical data from Maven, npm, and PyPI with real-time updates, and the tool maps dependency chains to actual application risk, not just package risk. Skip this if your organization runs mostly compiled languages or has minimal open-source exposure; the value proposition assumes you're drowning in third-party packages and need predictive coverage.
Tool that immunizes Windows systems against critical vulnerabilities
AI-driven tool that predicts software package vulnerabilities 90 days ahead
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing 360 High-Risk Vulnerability Immunization Tool V2.0 vs Sec1 Threat Vision for your vulnerability assessment needs.
360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). headquartered in China. Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..
Sec1 Threat Vision: AI-driven tool that predicts software package vulnerabilities 90 days ahead. built by Sec1. headquartered in India. Core capabilities include 90-day vulnerability forecast using AI/ML algorithms, Historical vulnerability data analysis from Maven, npm, and PyPI, Multi-ecosystem package coverage (Java, Node.js, Python)..
Both serve the Vulnerability Assessment market but differ in approach, feature depth, and target audience.
Get strategic cybersecurity insights in your inbox